Evidence map›Paper›PMID 31949986›Full record

ArticleAnatomy & cell biology2019

Neuregulin 1/ErbB4 signaling attenuates neuronal cell damage under oxygen-glucose deprivation in primary hippocampal neurons.

Ji-Young Yoo, Han-Byeol Kim, Seung-Yeon Yoo, Hong-Il Yoo, Dae-Yong Song, Tai-Kyoung Baik, Jun-Ho Lee, Ran-Sook Woo

Abstract read
In one paragraph

Article in Anatomy & cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Neuregulin-1 inhibits CoClMolecular brain · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ji-Young YooDepartment of Anatomy and Neuroscience, Eulji University College of Medicine, Daejeon, Korea.ORCID 0000-0003-3549-3952
Han-Byeol KimDepartment of Anatomy and Neuroscience, Eulji University College of Medicine, Daejeon, Korea.ORCID 0000-0002-6190-1078
Seung-Yeon YooDepartment of Anatomy and Neuroscience, Eulji University College of Medicine, Daejeon, Korea.ORCID 0000-0002-7713-2103
Hong-Il YooDepartment of Anatomy and Neuroscience, Eulji University College of Medicine, Daejeon, Korea.ORCID 0000-0002-7405-471X
Dae-Yong SongDepartment of Anatomy and Neuroscience, Eulji University College of Medicine, Daejeon, Korea.ORCID 0000-0001-5775-6288
Tai-Kyoung BaikDepartment of Anatomy and Neuroscience, Eulji University College of Medicine, Daejeon, Korea.ORCID 0000-0002-0992-7246
Jun-Ho LeeDepartment of Emergency Medical Technology, Daejeon University, Daejeon, Korea.ORCID 0000-0003-1572-1225
Ran-Sook WooDepartment of Anatomy and Neuroscience, Eulji University College of Medicine, Daejeon, Korea.ORCID 0000-0002-2128-9291
Eulji University · KRDaejeon University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hippocampus is one of the most important brain areas of cognition. This region is particularly sensitive to hypoxia and ischemia. Neuregulin-1 (NRG1) has been shown to be able to protect against focal cerebral ischemia. The aim of the present study was to investigate the neuroprotective effect of NRG1 in primary hippocampal neurons and its underlying mechanism. Our data showed oxygen-glucose deprivation (OGD)-induced cytotoxicity and overexpression of ErbB4 in primary hippocampal neurons. Moreover, pretreatment with NRG1 could inhibit OGD-induced overexpression of ErbB4. In addition, NRG1 significantly attenuated neuronal death induced by OGD. The neuroprotective effect of NRG1 was blocked in ischemic neurons after pretreatment with AG1478, an inhibitor of ErbB4, but not after pretreatment with AG879, an inhibitor of ErbB2. These results indicate an important role of ErbB4 in NRG1-mediated neuroprotection, suggesting that endogenous ErbB4 might serve as a valuable therapeutic target for treating global cerebral ischemia.

Indexed as

Cell deathErbB4Global cerebral ischemiaNRG1Oxygen-glucose deprivation

Identifiers

PMID31949986
PMCPMC6952697
OpenAlexW2999071198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.